- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07770776
Short Term Effects of Early Respiratory Muscle Training on Respiratory Muscle Strength in Inpatient Acute Stroke
Short-Term Effects of Early Combined High-Intensity Interval Inspiratory and Expiratory Muscle Training on Respiratory Muscle Strength in Inpatients With Acute Stroke
This study aims to determine the early effectiveness of combined high-intensity interval inspiratory and expiratory muscle training in hospitalized patients with acute stroke. Participants will be assigned to receive either combined high-intensity interval inspiratory and expiratory muscle training or conventional diaphragmatic breathing exercises.
The main questions this study aims to answer are whether the combined high-intensity interval inspiratory and expiratory muscle training can improve:
- inspiratory muscle strength, measured using maximal inspiratory pressure;
- expiratory muscle strength, measured using maximal expiratory pressure;
- chest expansion, measured using thoracic expansion; and
- the ability to sustain speech on a single breath, measured using the single-breath count test.
Researchers will compare changes before and after the intervention between the two groups to determine whether combined high-intensity interval inspiratory and expiratory muscle training provides greater early improvement than conventional diaphragmatic breathing exercises in hospitalized patients with acute stroke.
Studieoversikt
Status
Forhold
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
North Sulawesi
-
Manado, North Sulawesi, Indonesia
- Prof. R. D. Kandou General Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Male or female participants aged 18 years or older.
- First-ever acute ischemic stroke, with stroke onset 2 to 14 days before enrollment, confirmed by computed tomography (CT) or magnetic resonance imaging (MRI).
- National Institutes of Health Stroke Scale (NIHSS) score ≥5, with the presence of hemiparesis.
- Baseline maximal inspiratory pressure (MIP) <80 cmH₂O.
- Baseline maximal expiratory pressure (MEP) <68 cmH₂O.
- Able to understand instructions and participate in the respiratory muscle training program.
- Willing to comply with the study protocol and provide written informed consent.
Exclusion Criteria:
- Resting blood pressure >160/100 mmHg.
- Resting peripheral oxygen saturation (SpO₂) <92%.
- Resting heart rate <40 beats/min or >110 beats/min.
- Fever, defined as body temperature ≥37.5°C.
- Previous participation in or experience with a respiratory muscle training program.
- Presence of chronic pulmonary disease.
- Presence of a tracheostomy tube.
- Presence of unstable cardiac disease.
- Presence of another neurological disorder associated with respiratory dysfunction.
- Presence of an orthopedic or musculoskeletal condition that significantly interferes with respiratory function or the ability to perform respiratory muscle training.
- History of major thoracic or abdominal surgery within the previous 3 months.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Intervention Group
High-Intensity Interval Inspiratory and Expiratory Muscle Training
|
High-intensity interval inspiratory and expiratory muscle training is performed using the BigBreathe Double Action IMT/PEP device, which provides resistance during inspiration and expiration.
Participants perform the exercise in a semi-Fowler position using a mouthpiece with an airtight lip seal.
Training is performed once daily for 5 consecutive days, with five 2-minute sets per session and approximately 1 minute of rest between sets.
Inspiratory resistance is set at 50% of MIP and expiratory resistance at 30% of MEP.
|
|
Aktiv komparator: Control Group
Conventional Diaphragmatic Breathing Exercise
|
Diaphragmatic Breathing Exercise for 15 minutes in a semi-Fowler position.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Maximal Inspiratory Pressure
Tidsramme: Baseline and Day 3
|
Maximal inspiratory pressure (MIP) is used to assess inspiratory muscle strength.
Participants perform a maximal inspiratory effort against an occluded airway starting from residual volume.
MIP is recorded in centimeters of water (cmH₂O).
A greater magnitude of MIP indicates greater inspiratory muscle strength.
|
Baseline and Day 3
|
|
Maximal Expiratory Pressure
Tidsramme: Baseline and Day 3
|
Maximal expiratory pressure (MEP) is used to assess expiratory muscle strength.
Participants perform a maximal expiratory effort against an occluded airway.
MEP is recorded in centimeters of water (cmH₂O).
Higher MEP values indicate greater expiratory muscle strength.
|
Baseline and Day 3
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Thoracic Expansion
Tidsramme: Baseline and Day 3
|
Thoracic expansion is assessed as the difference in chest circumference between maximal inhalation and maximal exhalation.
Chest circumference is measured using a measuring tape at a standardized thoracic level and is reported in centimeters (cm).
A greater difference indicates greater chest wall expansion.
|
Baseline and Day 3
|
|
Single-Breath Counting Test (SBCT) Score
Tidsramme: Baseline and Day 3
|
The Single-Breath Counting Test (SBCT) is a bedside assessment of respiratory function.
After a maximal inspiration, participants count aloud sequentially for as long as possible during a single exhalation.
The highest number reached during one breath is recorded as the SBCT score.
A higher score indicates a greater ability to sustain phonation during a single breath.
|
Baseline and Day 3
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 089/EA/KEPK-KANDOU/II/2026
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .